Results for
"[search-keyword]"
Sponsor content
1 result(s) found, displaying 1 to 1
-
Australian Public Assessment Report (AusPAR)Forxiga (dapagliflozin) was approved as an adjunct to diet and exercise in patients with type 2 diabetes mellitus for whom metformin is otherwise indicated but not tolerated. It was also approved as a combination therapy to be used with other drugs to improve glycaemic control.